WIRE)--New technology using deep learning and advanced algorithms to evaluate blood flow to the heart is now being used in English hospitals to fight against coronary heart disease. Coronary heart disease (CHD) is one of the leading causes of death in the UK. It is responsible for more than 66,000 deaths each year and it is estimated that 2.3 million people in the UK are currently living with the diseasei. CHD develops when the arteries leading to the heart narrow or become blocked, which can reduce blood flow, and cause chest pain and heart attacksii. The HeartFlow FFRct Analysis is being supported by NHS England as part of the Innovation and Technology Payment (ITP) programme to help physicians better diagnose coronary heart disease.
Advances in artificial intelligence (AI) are happening at a much quicker pace than anyone could have predicted. This emerging technology is now being used by businesses and is even finding its way into consumer products. One industry that has fully embraced AI is healthcare and doctors and other hospital staff are using advanced machine learning algorithms to solve problems in new ways. TechRadar Pro spoke with HeartFlow's Founder and Chief Technology Officer Charles A. Taylor to learn more about how the company is using deep learning to build 3-D models of patients' hearts to provide doctors with a safer and more effective way of diagnosing cardiovascular disease. HeartFlow has pioneered technology to help clinicians diagnose coronary heart disease (CHD).
Suki, a startup that makes an AI-powered voice assistant for doctors, received two pieces of news from major clients less than three weeks ago. The first was that they'd need the product to accommodate telemedicine visits. The second was that they'd need autofilled clinical notes to quickly process patients who test positive for COVID-19 -- "Hey, Suki, write up a completed clinical note for COVID-19." The clients sent Suki their requirements and the data they'd gathered so far, and CEO Punit Soni called a meeting with his COO, head of customer success, product lead, sales lead and marketing lead. The meeting lasted 20 minutes.
Information Age discusses how artificial intelligence is transforming the NHS, and its potential in other sectors too with Charles A. Taylor, founder and chief technology officer at HeartFlow. The potential for AI in healthcare is tremendous as it increasingly becomes integrated into the healthcare ecosystem. AI is transforming the way doctors deliver cost-effective, high-quality diagnostic and treatment services to their patients. For example, the technology can identify patterns and anomalies in diagnostic data from medical scans at a speed and volume that humans are simply unable to replicate. The processing power of AI has applications far beyond providing simple diagnoses.
This post was authored by Elizabeth Fernandez, senior public information representative with UCSF News. "Intelligent Imaging" Hub will harness computational tools in medical imaging to improve patient care. UC San Francisco is launching a new center to accelerate the application of artificial intelligence (AI) technology to radiology, leveraging advanced computational techniques and industry collaborations to improve patient diagnoses and care. The Center for Intelligent Imaging, or ci2, will develop and apply AI to devise powerful new ways to look inside the body and to evaluate health and disease. Investigators in ci2 will team with Santa Clara, California-based NVIDIA Corp., an industry leader in AI computing, to build infrastructure and tools focused on enabling the translation of AI into clinical practice.